METiS BioTech announces China's First AI-Enabled Formulation Drug Candidate to Complete Phase III Clinical Trial
MTS-004 Poised to Fill an Unmet Need in the Treatment of Pseudobulbar Affect (PBA) BEIJING, China, Oct. 23, 2025 /PRNewswire/ -- METiS TechBio, a global leader in AI-driven nanodelivery and formulation innovation, today announced that its internally...
Power International Holding (PIH) closes a landmark transaction to finance the acquisition of 100% of Mobile Telecom - Service LLP (MTS) from Kazakhtelecom JSC
DOHA, Qatar, Jan. 20, 2025 /PRNewswire/ -- Power International Holding (PIH), a globally recognized Qatari-based conglomerate, has officially completed the acquisition of a 100% participatory interest in Mobile Telecom-Service LLP (MTS) from...